---
schema_version: "secwatch.filing_event.v1"
accession: "0000355811-26-000021"
form_type: "8-K"
ticker: "GNTX"
cik: "0000355811"
company_name: "GENTEX CORP"
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:19:18.236340+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Gentex Q1: core sales up 2% despite production drop; China revenue falls 29% on tariffs; guides FY rev higher

## Summary
- Q1 consolidated net sales $675.4M (+17% YoY); core Gentex (ex-VOXX) $586.8M (+2% vs -3% global production).
- GAAP EPS $0.46 (vs $0.42), adjusted EPS $0.48 (vs $0.43); net income $98.5M up from $94.9M.
- FY2026 revenue guidance raised to $2.65-2.75B (from $2.60-2.70B); gross margin unchanged 34-35%.
- China revenue down 29% YoY to ~$28M; cumulative IEEPA tariffs paid directly ~$42M, $15M capitalized in inventory.
- Repurchased 3.3M shares for $71.6M in Q1; 32.6M shares remaining under buyback plan.

## SEC filing metadata
- accession: 0000355811-26-000021
- form_type: 8-K
- ticker: GNTX
- cik: 0000355811
- company_name: GENTEX CORP
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/355811/000035581126000021/0000355811-26-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/355811/000035581126000021/gntx-20260424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000355811-26-000021
- JSON: https://secwatch.observer/filing/0000355811-26-000021.json
- Plain text: https://secwatch.observer/filing/0000355811-26-000021.txt

## Key facts
- Earnings Releases
  GENTEX CORP reported first quarter ended March 31, 2026 results: revenue $675.4 million, net income $98.5 million, EPS $0.46.
  - Period: first quarter ended March 31, 2026
  - Revenue: $675.4 million
  - Net income: $98.5 million
  - EPS: $0.46
  - Result: reported results
  source text: medical devices, and consumer electronics, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights • Net sales: Consolidated $675.4 million; core Gentex (ex‐VOXX) $586.8 million • Gross margin: Consolidated 33.8%; core Gentex (ex‐VOXX) 34.0% • Consolidated Income from operations: (GAAP) $123.7 million; core Gentex
  evidence_url: https://www.sec.gov/Archives/edgar/data/355811/000035581126000021/0000355811-26-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.